| Vol. 6.46 – 16 December, 2022 |
| |
|
|
| Tumoral Prdm1 overexpression upregulated PD-L1 levels, dampening anti-tumor immunity in vivo, and neutralized the anti-tumor efficacy of Prdm1 overexpression in immune-competent mouse models. [Nature Communications] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators described the derivation of syngeneic induced pluripotent stem cells (iPSCs) engineered to determine the effects of Z alpha-1 antitrypsin heterozygosity in iPSC-hepatocytes. [Cell Reports] |
|
|
|
| Scientists dissected the impact of activated mTORC1 on the cell-cell interaction of Kupffer cells (KCs) and hepatocyte in immune-mediated hepatitis. In the liver from patients with AIH and mice administrated with Con-A, mTORC1 was activated in both KCs and hepatocytes. [Cell Death & Disease] |
|
|
|
| Mouse serum extracellular vesicles were isolated and identified using nanoparticle tracking analysis and transmission electron microscopy. Mouse hepatocytes and primary hepatic stellate cells were used to investigate the cell-to-cell crosstalk. [Journal of Cell Communication and Signaling] |
|
|
|
| Researchers established reliable in vitro non-alcoholic steatohepatitis models using different mixtures of variable ratios and concentrations of oleic acid and palmitic acid combinations using HepG2 cell lines. [Molecular and Cellular Biochemistry] |
|
|
|
| Hepatic architecture, liver size, endothelial differentiation, and angiocrine functions were unaltered in Lyve-1-KO. Hyaluronan plasma levels were significantly increased in Lyve-1-KO. [Cancer Cell International] |
|
|
|
| Scientists evaluated the protection and the mechanisms of action of citrus flavanone metabolites, hesperetin 7-glucuronide and 3-(4′-hydroxyphenyl) propanoic acid, on pancreatic β-cell function under oxidative stress induced by cholesterol using the global proteomics approach. [Food & Function] |
|
|
|
| In the presence of palmitic acid, reactive oxygen species production was increased at three hours, followed by enhancement of expression of p-PERK, ATF4, p-eIF2α, CHOP, and TXNIP and p-p62 and LC3II/LC3I ratio, in both primary hepatocytes and AML12 cells. [Food and Chemical Toxicology] |
|
|
|
| Inflammation is an important driver in the pathogenesis of non-alcoholic steatohepatitis, and the mechanisms underlying inflammation in non-alcoholic fatty liver disease represent possible therapeutic targets. [Journal of Endocrinology] |
|
|
|
|
|
| Recovery of the native liver depends on activation of apoptotic and regenerative pathways, including the integrated stress response (ISR; e.g., PERK), p53, and HNF4α. [Trends in Molecular Medicine] |
|
|
|
| The blockage of spleen tyrosine kinase (SYK) activity using small molecule modulators is considered as a significant therapeutic strategy against liver diseases, and both hepatic SYK and non-hepatic SYK could become highly promising therapeutic targets. [Heliyon] |
|
|
|
|
| Genflow has announced that it has filed a new patent application with the US Patent and Trademark Office that relates to variants of Sirtuin-6, and the gene variant’s therapeutic uses for the treatment of two disorders involving the liver: NAFLD, and non-alcoholic steatohepatitis. [Genflow (First Longevity Ltd)] |
|
|
|
| The University of Kentucky Markey Cancer Center has received renewed funding from the American Cancer Society to support a long-standing faculty research program. [University of Kentucky] |
|
|
|
|
| February 19 – 22, 2023 Banff, Alberta, Canada |
|
|
|
|
|
| Rutgers Biomedical and Health Sciences – Newark, New Jersey, United States |
|
|
|
| Mammoth Biosciences, Inc. – Brisbane, California, United States |
|
|
|
| The Ottawa Hospital Research Institute – Ottawa, Ontario, Canada |
|
|
|
| University of Oxford – Oxford, England, United Kingdom |
|
|
|
| Centre for Oncology and Immunology – Hong Kong, Hong Kong |
|
|
|
|